AKT1 and cancer: Previous studies indicated that EGCG can treat a variety of cancers by inhibiting this signaling pathway [18, 19], but it was not verified if EGCG exerted mechanism in the treatment of PLGC by targeting PI3K/Akt/mTOR pathway.